SCHEMBL18309294

SCHEMBL18309294

COC(=O)c1cc(C=O)c(N)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.50
ABL1 P00519 1/20 0.49
NQO2 P16083 6/20 0.45
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 7/20 0.42
HSD17B10 Q99714 3/20 0.42
GLA P06280 2/20 0.42
MAPT P10636 2/20 0.42
HPGD P15428 2/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
ATM Q13315 1/20 0.42
CFTR P13569 2/20 0.42
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9793695 0.83 GAA (0.59) GAAABL1NQO2KDM4EALDH1A1
SCHEMBL31056006 0.82 ERN1 (0.48) GAAABL1KDM4EALDH1A1MAPT
SCHEMBL31056011 0.82 ERN1 (0.48) GAAABL1KDM4EALDH1A1MAPT
SCHEMBL7762378 0.81 ABL1 (0.61) GAAABL1NQO2KDM4EALDH1A1
SCHEMBL19328721 0.81 GAA (0.72) GAAABL1NQO2KDM4EALDH1A1
SCHEMBL17632541 0.81 ALDH1A1 (0.50) GAAKDM4EALDH1A1HSD17B10GLA
SCHEMBL15823317 0.79 GAA (0.46) GAAABL1NQO2KDM4EALDH1A1
SCHEMBL15823315 0.79 GAA (0.46) GAAABL1NQO2KDM4EALDH1A1
SCHEMBL23774898 0.78 GAA (0.54) GAAABL1NQO2KDM4EALDH1A1
SCHEMBL2897626 0.78 GAA (0.62) GAAABL1NQO2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159510-A1 NOVEL PRMT5 INHIBITORS AMGEN INC. (US) 2023-05-25 US disclosed
US-20230159510-A1 NOVEL PRMT5 INHIBITORS AMGEN INC. (US) 2023-05-25 US disclosed
EP-4103558-A1 NOVEL PRMT5 INHIBITORS Amgen Inc. (US) 2022-12-21 EP disclosed
WO-2021163344-A1 NOVEL PRMT5 INHIBITORS AMGEN INC. (US) 2021-08-19 WO disclosed
WO-2021163344-A1 NOVEL PRMT5 INHIBITORS AMGEN INC. (US) 2021-08-19 WO disclosed
EP-3307730-B1 HERBICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2019-07-24 EP disclosed
US-10194660-B2 Herbicidal compounds SYNGENTA PARTICIPATIONS AG (CH) 2019-02-05 US disclosed
US-20180177190-A1 HERBICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2018-06-28 US disclosed
WO-2016198585-A1 HERBICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2016-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180177190-A1 HERBICIDAL COMPOUNDS DDT, CYP1B1, ATP1B1 GAA 295/4885ABL1 1304/4885NQO2 97/4885
US-20230159510-A1 NOVEL PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 GAA 3863/4885ABL1 432/4885NQO2 1214/4885
US-10194660-B2 Herbicidal compounds DDT, CYP1B1, ATP1B1 GAA 295/4885ABL1 1304/4885NQO2 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.